“I got lucky that I suck at golf. I threw my back out playing a sport that people usually enjoy in khakis.”
Anschutz Cancer Pavilion
1665 North Aurora Court
Aurora, CO 80045
“I got lucky that I suck at golf. I threw my back out playing a sport that people usually enjoy in khakis.”
Illustrating the University of Colorado Cancer Center’s research strength in the area of blood cancers, the American Cancer Society Journal recently asked CU Cancer Center members Andrew Kent, PhD, and Dan Pollyea, MD, MS, to give readers an update on the latest advances in leukemia treatment.
The fear, anger, and anxiety that come with a cancer diagnosis are only magnified in children, who—along with their family members—often need help working through the emotions that surround cancer diagnosis, treatment, and survivorship.
Growing up in Windsor, Colorado, Elijah Johnson thought he would grow up to be a professional musician. He never considered a career as a biomedical researcher. But that all changed when his mother was diagnosed with Li-Fraumeni Syndrome (LFS), a rare genetic mutation that increases the risk of cancer.
Can using over-the-counter cannabis products help cancer patients cope with issues like pain, anxiety, sleeplessness, and depression?
The University of Colorado Cancer Center is doubling down on its diversity, equity, inclusion, and access (DEIA) efforts in 2023, adding an associate director and deputy associate director of DEIA to its leadership team.
The International Cytokine and Interferon Society has recognized University of Colorado Cancer Center member Edward Chuong, PhD, with its 2023 ICIS-Regeneron New Investigator Award for Excellence in Cytokine and Interferon Research.
University of Colorado Cancer Center member Sachin Wani, MD, inaugural director of the Katy O. and Paul M. Rady Esophageal and Gastric Center of Excellence, is behind a new clinic for people with benign, complex conditions of the foregut, including complicated reflux cases, refractory esophageal strictures, and motility disorders such as achalasia and gastroparesis.
At the University of Colorado Cancer Center’s Office of Community Outreach and Engagement (COE), cancer center members are creating an interactive data platform to give researchers information on Colorado’s demographics, cancer burden, risk factors and health behaviors, environmental factors, and access to care across the cancer continuum.
University of Colorado Cancer Center member Marco Del Chiaro, MD, PhD, division chief of surgical oncology, is coordinating a new effort to standardize global diagnosis and treatment efforts for cystic tumor of the pancreas. More frequent than solid lesions, cystic tumors are usually detected incidentally and are often asymptomatic.
The statistics about radon exposure and lung cancer in Colorado are sobering: Lung cancer is the leading cause of cancer-related deaths in the state, and radon exposure is the second leading cause of lung cancer, after tobacco smoke.
Many of the side effects of cancer treatment are well-known, including nausea, fatigue, and weight loss.
Whether they are focused on middle school and high school students, college undergraduates, or current medical students, pipeline programs at the University of Colorado Cancer Center are designed to expose students of all ages and backgrounds to the world of cancer science and research, with a special focus on giving students from underrepresented backgrounds the opportunity to see themselves working in the field.
There’s no such thing as perfect timing when it comes to lung cancer, but Kathy Ballard got pretty close.
A new study published in Gastroenterologyaims to improve the effectiveness of screening and surveillance practices for early cancer detection in Barrett’s esophagus (BE).
Diana Cittelly, PhD, a longtime University of Colorado Cancer Center member and a researcher on cancer that spreads to the brain, has taken on a new role at the CU Cancer Center.
When Nathan Hammond traveled to Colorado from Fort Wayne, Indiana, to consult with University of Colorado Cancer Center specialists about his newly diagnosed esophageal cancer, his first stop was the esophageal and gastric cancer multidisciplinary clinic, where patients are seen by doctors from multiple specialties — including surgical oncologists, medical oncologists, radiation oncologists, pathologists, dietitians, and genetic counselors — all at the same time.
Look at the racing jersey created in his memory, and you’ll see images of everything Trevor Kling loved. Bright colors. Baseball. Pineapple. Bowling. Sports cars. Board games.
A new study published in the Journal of the National Cancer Institutebrings researchers and oncologists one step closer to better understanding the complexities of PD-1 inhibitors, a common type of immunotherapy, and their intracellular signaling on cancer behavior.
In the earliest days of specialized cancer care, two things often happened: either individual oncologists were burdened with the expectation to know everything, or patients were sent on treatment journeys that could involve multiple visits with multiple clinicians in multiple locations.
As the field of cancer care has grown and evolved, buoyed by tremendous strides in research and therapeutics, patients could increasingly and reasonably hope to live many years, rather than many weeks or months, after a diagnosis. A significant contributor to this hope has been the move toward multidisciplinary care.
Barb Spanjer lay on the floor of her office. She had never been so tired. Her stomach and left side ached, and the pain under her left shoulder blade was relentless. She had seen her doctor a couple of times that autumn of 2017, but the medicine for the ulcer he suspected she had wasn’t working. She had been too tired and too busy running the construction company she and her husband, Steve, owned to follow up with the doctor. But it was getting harder to ignore the symptoms. Something just wasn’t right.
Clinical trials are an important part of cancer care, giving people with cancer potentially life-saving early access to new medications and treatments and making sure those medications and treatments are safe and efficacious before approving them for widespread use.
For Doug Scanlon, last year’s Walk to End Colon Cancer was a victory lap. This year, it’s more like a homecoming.
Cancer researchers have long been interested in the resistance that lung cancer patients develop to targeted therapies aimed at specific mutations. Though the therapies provide significant remission at first, the cancer eventually finds a way to return.
For the past four years, University of Colorado Cancer Center member Sarah Tevis, MD, has focused her research on the psychosocial outcomes of breast surgery for women with breast cancer — specifically comparing patient-reported outcomes three and six months after receiving a lumpectomy (surgery in which just the tumor and some of the surrounding cells are removed) and a mastectomy (surgery to remove the entire breast).
The good news for people with multiple myeloma is that treatments exist that almost always put the cancer into deep remission soon after it’s diagnosed. The bad news for people with the blood cancer, though, is that even though that remission can last several years, almost all patients eventually relapse — and the disease that returns becomes increasingly difficult to treat.
It’s one thing to develop cancer treatment guidelines in the U.S., where even the smallest health centers have access to the same basic technology for treatment and testing. But what about creating guidelines for oncologists in Sub-Saharan Africa, where access to medical resources can be limited and the disease can present differently?
Cancer, the author Susan Sontag wrote, is “the disease that doesn’t knock before it enters.”
It’s the scary C-word that a large and continually growing body of research demonstrates has effects far beyond its physical symptoms. A cancer diagnosis, especially one made in the later stages of the disease, often impacts a person’s mental and emotional health in ways that can be unexpected and broad-reaching.
Early detection of cancer plays a vital role in improving cancer survival rates. Detecting cancer early allows for timely intervention, stopping the cancer before it metastasizes, and increasing the effectiveness of treatment options.
At the University of Colorado Cancer Center, many members are focused on detecting cancer early by providing greater access to screening and educating the community on options.
Philanthropy is critical to the mission of the University of Colorado Cancer Center. Donors who are able to make gifts of any amount help CU Cancer Center members contribute to breakthrough research and improved patient outcomes.
Over the past several decades, doctors and researchers have gotten much better at detecting and treating cancer. A cancer diagnosis, however, is still often costly to treat, not to mention the physical and emotional toll that treatment can take.
The best way to avoid a diagnosis altogether? Stop cancer before it starts.
Sean Ryan did everything right.
Ryan’s father died of colorectal cancer when he was just 45, so Ryan knew he was at high risk for the disease. When he turned 50, he made plans to get a screening colonoscopy. (In 2021, the U.S. Preventive Services Task Force lowered the recommended screening age for colorectal cancer from 50 to 45 for men and women at average risk for colorectal cancer.)
Driven in part by an increase in breast cancer diagnoses in younger women — particularly in Black women — the United States Preventive Services Task Force (USPSTF) — has proposed lowering the recommended age for beginning regular mammograms from 50 to 40. The USPSTF recommends that women at average risk for breast cancer get screening mammograms every other year.
Evelinn Borrayo, PhD, has made it her mission to eliminate cancer disparities in Colorado.
To start with, there was his usual schedule of national travel for his job as a Wall Street journeyman – he was always flying somewhere. Add to that moving to Castle Rock from San Francisco, plus a love for concerts and baseball games and whatever else life offers, and it’s no wonder that Lincoln Yersin was feeling run down.
But this run down? This exhausted? He went to see his primary care provider in San Francisco a few times, had a few tests, and the diagnosis was stress.
Intraductal papillary mucinous neoplasms (IPMNs) are cystic lesions that can form by the ducts of the pancreas. They generally are asymptomatic and discovered in the course of testing for other conditions.
In its early stages, bladder cancer can be easy to ignore or write off as something it isn’t – a UTI, a bladder infection, or other conditions that are commonly treated with an antibiotic.
May is Brain Tumor Awareness Month, which makes it a perfect time to turn the spotlight on pediatric brain cancer. Brain cancer is the second most common cancer in children, after leukemia, and brain tumors are the most common solid tumors in children and adolescents, with more than 4,000 new diagnoses each year, according to the American Cancer Society.
Paul Herzegh’s lung cancer story began six years ago on a beautiful April morning, roadtripping back home to Boulder from visiting friends in Virginia. He was 68, in otherwise good health, and felt some small kinks in his chest.
Hardly any time later, he had a diagnosis: stage 4 adenocarcinoma, a type of cancer that originated in the cells lining the outside of his lungs. At that point, he didn’t know much beyond “the conventional wisdom that 'lung cancer is a killer,’” he explained Saturday evening, emphasizing the air quotes because, well, the conventional wisdom was wrong.
Thanks to the Colorado Cancer Screening Program at the University of Colorado Cancer Center, more than 4,000 people from medically underserved populations received colorectal cancer screening over the past two years — individuals who likely would not have sought the screening out on their own.
Cancer is a disease of ripples – from symptoms that precede a diagnosis to treatment, side effects, and goals for long-term survival. It can impact every facet of life, for the person who receives the diagnosis as well as the person who is their caregiver.
A unique treatment combining radiation and immunotherapy can eradicate pancreatic tumors while stopping the cancer from spreading, according to a new study by researchers at the University of Colorado Cancer Center.
For 30% to 40% of lymphoma patients who receive CAR T therapy, the treatment is a godsend. Typically given to lymphoma patients for whom other treatments have proven ineffective, CAR T therapy involves removing immune cells from the body via a blood draw, reengineering them to become better cancer fighters, then reintroducing them to the bloodstream, where they seek out and destroy cancer cells.
When the PACT Act went into effect January 1, after being signed into law in August, many U.S. veterans were able to access benefits for an expanded list of health conditions presumed to be caused by exposure to toxic substances.
Cancer patients younger than 65 who are discharged to a skilled nursing facility following hospitalization are less likely to receive cancer treatment and hospice care before death, new University of Colorado Cancer Center research shows.
Whether they are coming from across the state, across the region, or across the country, more than 1,000 people each year arrive at the University of Colorado Cancer Center for treatment, surgery, or a second opinion on their cancer diagnosis.
For many pediatric cancer patients and their families, “scanxiety” is a very real and very scary feeling – the worry that can precede scans before treatment, and the uncertainty stemming from scans after treatment is completed.
Nathan Hammond knew things were getting bad when his doctors had to put the feeding tube in.
Whole-brain radiation therapy used to treat brain metastases is a significant cancer treatment that, while generally well-tolerated, can have serious long-term side effects, including dementia. Neither clinicians nor patients undertake it lightly.
There’s a growing body of research supporting the satisfactions of gardening, from its positive impact as a mental health intervention to its association with improvement in cognitive function and reduction in stress, anger, and fatigue.
For her innovative research on how cannabinoids affect the tumor immune microenvironment in melanoma, University of Colorado Cancer Center member Camille Stewart, MD, has been named to the 2023 cohort of the National Cancer Institute’s Early-Stage Surgeon Scientist Program (ESSP). The National Cancer Institute coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH).
Before receiving a pancreatic cancer diagnosis eight years ago – a diagnosis that resulted from persistent self-advocacy – Carolyn Degrafinried spent one awful weekend wondering if she was losing her mind.
Squamous cell head and neck cancers — cancers that develop in the outer layers of tissue in the oral cavity, throat, larynx, and sinonasal cavity — are the sixth most prevalent cancer worldwide. The five-year survival rate for this type of cancer is 40% to 50%, with a worse prognosis for patients with advanced disease.
Pediatric osteosarcoma patients who are Hispanic or live in areas of high language isolation are more likely to have metastatic disease at the time of diagnosis, recently publish research shows.
Earlier this month, medical professionals, patient advocates, industry innovators, federal policymakers, and public health officials, including two members of the University of Colorado Cancer Center, gathered at the White House for the Cancer Moonshot Colorectal Cancer Forum.
For women with dense breasts, getting a mammogram to screen for breast cancer can be something of a double whammy. Not only is cancer more difficult to detect in dense breasts, but dense breasts also are a risk factor for developing breast cancer in the first place.
When surgeons from the Netherlands needed help establishing a national program for patients with hard-to-treat pancreatic cancer, they knew just whom to turn to: Marco Del Chiaro, MD, PhD, professor and division chief of surgical oncology in the University of Colorado Department of Surgery.
March is Colorectal Cancer Awareness Month, and with the recent news that the disease is on the rise among people under 55, it’s more important than ever for people to understand the screening options for colorectal cancer.
Channing E. Tate, PhD, MPH, University of Colorado Cancer Center Rising Star, has seen through her personal and professional experiences how aging populations and communities of color often fall through the cracks of health care, especially at the end of life.
Funding from the Paul R. O’Hara Seed Grant Fund at the University of Colorado Anschutz Medical Campus will allow CU Cancer Center member Akshay Chauhan, MD, to explore new methods of detecting and treating esophageal cancer.
Over the past decade, human papillomavirus (HPV) has increasingly been identified as a significant cause of certain head and neck cancers – for example, evidence suggests it causes 70% of oropharyngeal cancers in the United States.
Already regarded as one of the country’s leaders in CAR T-cell therapy, University of Colorado Cancer Center member M. Eric Kohler, MD, PhD, has received a $150,000 Scholar Award from the American Society of Hematology (ASH) to investigate a method to make CAR T cells function even better.
University of Colorado Cancer Center members Michael Leibowitz, MD, PhD, and Dan Regan, DVM, PhD, have received an $800,000 grant from the V Foundation for Cancer Research, co-founded by ESPN and legendary basketball coach Jim Valvano, to study a new potential treatment for pediatric osteosarcoma that spreads to the lungs.
Four early career researchers from the University of Colorado Cancer Center have received Institutional Research Grants (IRGs) from the American Cancer Society (ACS) for 2023 through the parent grant awarded to the CU Cancer Center. IRGs are intended to support junior faculty members to obtain preliminary results that will enable them to compete successfully for federal research grants.
For many people who receive a cancer diagnosis, one of the first things they want is information – about the cancer itself, about treatment options, about side effects they may experience, about what it all means.
Cancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors and oncogenes. Mutations in tumor suppressor genes can allow tumors to grow unchecked – a case of no brakes – while mutations in oncogenes can activate cell proliferation, pushing the gas pedal all the way to the floor.
A project co-created by University of Colorado Cancer Center leader Jamie Studts, PhD, to boost lung cancer screening rates in Kentucky has proven so successful that Studts has received a grant from the Bristol Myers Squibb Foundation (BMSF) to create an enhanced version of the program that will roll out in two more states in the coming years.
Researchers at the University of Colorado Anschutz Medical Campus have discovered a drug combination that might offer a better prognosis for children diagnosed with MYC amplified Medulloblastoma, an often deadly form of brain cancer. The research was conducted in collaboration with the German Cancer Consortium (DKTK) University Hospital Dusseldorf.
In addition to the research and clinical work she performs as a member of the University of Colorado Cancer Center, Swati Patel, MD, also just completed a one-year term as president of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC), an international professional medical organization dedicated to taking care of patients who may be at increased risk of GI cancer based on family history and genetics.
When his mom fell off a ladder on New Year’s Eve a number of years ago, after deciding that was as good a night as any to clean the leaves from her gutters, one of the first things Ross Camidge, MD, PhD, did after she got home from the hospital was take her pulse.
When it comes to treating cancer, doctors have many tools in their arsenal. For decades, cancer was treated with surgery, chemotherapy and radiation — broad tools that affect healthy cells along with the cancer cells they are meant to eradicate.
Researchers from the University of Colorado Anschutz Medical Campus have identified a new feature indicative of the chance of recurrence of Gastrointestinal Stromal Tumors (GISTs).
As growing numbers of people diagnosed with cancer receive testing to have their cancer genetically sequenced, researchers and clinicians are learning volumes more about specific mutations and genetic alterations that can occur in each type of cancer.
A necessary part of the scientific process is sometimes being wrong, and Eric Pietras, PhD, was wrong. He’s the first to admit it.
When Pietras, a University of Colorado Cancer Center member and associate professor of hematology, joined the CU School of Medicine in 2015, a significant body of research suggested that inflammation activated blood-forming stem cells, which normally are dormant in bone marrow.
On January 2, tennis great Martina Navratilova revealed that she has been diagnosed with two unrelated cancers: stage 1 throat cancer and early-stage breast cancer.
Former Denver Broncos running back Ronnie Hillman, 31, died Wednesday of a rare type of kidney cancer that disproportionately impacts young people who are Black with sickle cell trait or sickle cell disease.
Jane Hart is a lot of things: extremely proud mom of Shelby, daughter extraordinaire and apple of Jane’s eye. Dog mom to (deservedly spoiled) Maizy, Taco, Winnie, and Walter. Collector of Talavera pottery. Unabashed “Real Housewives of Salt Lake City” fan. A surprising 71, because she looks at least 10 years younger.
Cancer survivor – stage 4 laryngeal cancer that necessitated a tracheostomy and laryngectomy, that forced her to relearn how to breathe and talk.
A newly opened endoscopy suite at Salud Family Health in Longmont highlights the importance of longstanding partnerships between the University of Colorado Cancer Center and community stakeholders in supporting underserved populations who otherwise might not receive vital cancer screening services.
Today, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and after surgery for pancreatic cancer as the most effective combination for patients.
Actress Kirstie Alley, best known for her role as Rebecca Howe on the 1980s sitcom “Cheers,” died Monday at age 71. According to a representative for the actress quoted in People magazine, Alley died from colon cancer after a short battle with the disease.
New research from the University of Colorado (CU) Cancer Center highlights the need for additional data collection for women hoping to have successful pregnancies while undergoing treatment for lung cancer. Specifically, they focus on the diagnosis of advanced oncogene-driven non-small cell lung cancer (NSCLC) that disproportionately affects women of reproductive age.
Two important numbers to keep in mind are that 50.5% of the U.S. population is female, and that cancer will account for more than 606,000 deaths in the United States this year, making it the second-leading cause of death.
A new study from researchers at the University of Colorado Anschutz Medical Campus has identified a less invasive way to treat a subset of head and neck cancers that could potentially change the standard of care for patients.
A promising new study released by the University of Colorado Cancer Center suggests that recurrence of certain cancers can be significantly decreased by irradiating only a select set of lymph nodes near a tumor rather than all of them.
In the course of her research studying employment and cancer, Cathy J. Bradley, PhD, MPA, deputy director of the University of Colorado Cancer Center, has heard from people diagnosed with cancer who would skip a chemotherapy treatment rather than skip work and risk losing their job.
Xander Bradeen began his undergraduate studies at the University of Colorado Boulder planning to major in neuroscience as a pre-med student, the first in his family to pursue a college education. Then he learned about prairie voles.
New research conducted in the lab of University of Colorado Cancer Center co-deputy director James DeGregori, PhD, may explain why acute myeloid leukemia (AML) cells that reside in the bone marrow are more resistant to medication than AML cells found in the blood and elsewhere in the body.
Laura Foote is now three years out from her pancreatic cancer diagnosis, thanks to a surgery performed by Richard Schulick, MD, MBA, director of the University of Colorado Cancer Center and chair of the Department of Surgery.
University of Colorado Cancer Center member Erin Schenk, MD, PhD, has been named one of the CU School of Medicine 2022 Translational Research Scholars and received four-year grant support to facilitate exploration and new lines of research.
Corralling four research programs, 12 shared resources, a 28-member leadership team, and a $23 million grant is a huge job — but it’s one that Michaela Montour has performed at the University of Colorado Center with ease for more than 20 years.
Mammograms are a vital tool for breast cancer screening. They can detect tumors even before a woman experiences signs or symptoms of cancer, and are sensitive enough to register changes to breast tissue as small as a grain of sand.
A significant body of research has shown that having regular mammograms can lower a woman’s risk of dying from breast cancer.
University of Colorado Cancer Center member Bryan Haugen, MD, always knew he was a science person. His question was if he wanted to be a MD or a PhD. After completing his bachelor’s degree at Saint Olaf College in Minnesota, he did a few years of research at the Mayo Clinic before starting medical school there.
Cancer becomes especially dangerous when it metastasizes — or spreads — to other parts of the body, including the brain. Breast cancer is more likely than many other cancers to spread to the brain, due in part to the large amounts of estrogen present in areas including the hippocampus, hypothalamus, and amygdala.
Amanda Vegter did not have time for whatever it was that she felt on the side of her left breast.
She was six weeks into her fourth year of veterinary school, she had backpacking trips to go on with her boyfriend, walks to go on with her two dogs, plus plans for a summer externship in South Africa. She was busy and happy and it was probably nothing.
But that firm spot she first felt on her breast in January 2021 while working out at her boyfriend’s house didn’t just go away. Now she can look back and shake her head – of course it was breast cancer.
Scarlet Doyle was 29 when she was diagnosed with angiosarcoma, a rare type of breast cancer. She had found a lump and had to advocate for herself to get her breast cancer diagnosis. After having her care transferred to the University of Colorado Cancer Center, she was seen by Breelyn Wilky, MD, associate professor of medical oncology and deputy associate director of clinical research at the CU Cancer Center, and Gretchen Ahrendt, MD, professor of surgical oncology.
Jan Lowery, PhD, MPH, who started her career as a researcher at the University of Colorado Cancer Center, returned September 1 as assistant director for dissemination and implementation for the Office of Community Outreach and Engagement at the CU Cancer Center. In her new role, Lowery will lead efforts to develop, conduct, and disseminate implementation-focused projects in cancer prevention, early detection, and survivorship.
A team of scientists and University of Colorado Cancer Center members are collaborating to understand pre-malignancy in lung cancer and decrease the risk of developing the disease, supported by a grant to promote such multi-investigator research.
The best screening test for colorectal cancer is the screening that gets done, because it decreases a person’s chances of getting colorectal cancer and significantly reduces their risk of dying from colorectal cancer.
As lead investigator or sub-investigator on numerous clinical trials at the University of Colorado Cancer Center — many of them investigating new treatments for head and neck cancer — Jessica McDermott, MD, has been instrumental in improving access to cancer clinical trials for patients from medically underserved communities.
More than 85 researchers from five different institutions around Colorado, including the University of Colorado School of Medicine, Colorado State University, and CU Boulder, gathered in the newly opened Anschutz Health Sciences Building on the CU Anschutz Medical Campus on August 19 for the 2022 Genome Regulation Summer Symposium.
Former “TODAY” show anchor Katie Couric revealed last week that she was diagnosed with breast cancer in summer 2022. Couric appeared on “TODAY” on October 3 to talk about her diagnosis, saying she was lucky her cancer was detected during a routine mammogram and urging other women to keep up with their mammograms.
University of Colorado Cancer Center members Moumita Ghosh, PhD, and Eric Clambey, PhD, have received a grant from the American Lung Association (ALA) to study how epithelial progenitor cells and immune cells may impact each other to shape the outcome of lung cancer.
When a person has lived with colorectal cancer for a long time, and gotten to the point of not responding to therapies as much or at all, it’s common to develop cachexia. This debilitating condition is a multi-systemic wasting syndrome that can cause weight loss, a loss of muscle and bone mass, fatigue, and frailty.
Researchers from the University of Colorado Cancer Center on the University of Colorado Anschutz Medical Campus have created a new way of measuring cancer lesions’ response to treatment that could better inform the development of new cancer drugs.
Prostate cancer is the most common cancer in men and, when caught and treated early, is considered curable. But when prostate cancer becomes metastatic, meaning it spreads to distant organs, it is no longer considered curable and novel treatment strategies are needed.
Prostate cancer is the second most common and deadly cancer in the United States. The American Cancer Society estimates that 1 in 8 men will receive a prostate cancer diagnosis in their lifetime. Treatment techniques range from aggressive therapies such as radical prostatectomy or radiation therapy to targeted therapies that treat only the affected cancer cells.
In this episode of "How This Is Building Me," Drs Camidge and Vokes discuss the span of countries and institutions along Dr Vokes’ journey to MD Anderson Cancer Center, how Dr Vokes balances research and work in the clinic, and how the correct mentors can help shape career paths in oncology.
Horse Barn Community Garden is in Five Points’ Curtis Park, near downtown Denver. This is where you’ll often find Charlotte Griffin, watering the vegetables.
A novel therapeutic approach that combined radiation and immunotherapy demonstrated the ability to eliminate pancreatic tumors and halt metastases.